LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $206,000 | -48.4% | 1,353 | -57.4% | 0.02% | -50.0% |
Q1 2019 | $399,000 | -72.0% | 3,175 | -63.2% | 0.03% | -56.2% |
Q1 2018 | $1,423,000 | +22.5% | 8,618 | +1.6% | 0.07% | +23.7% |
Q4 2017 | $1,162,000 | +3.8% | 8,484 | +3.3% | 0.06% | -3.3% |
Q3 2017 | $1,119,000 | +7.1% | 8,215 | -4.6% | 0.06% | +1.7% |
Q2 2017 | $1,045,000 | +15.3% | 8,609 | +0.6% | 0.06% | +13.2% |
Q1 2017 | $906,000 | -17.8% | 8,558 | -21.1% | 0.05% | -23.2% |
Q4 2016 | $1,102,000 | -14.3% | 10,849 | -13.9% | 0.07% | -15.9% |
Q3 2016 | $1,286,000 | -14.4% | 12,604 | +0.1% | 0.08% | -19.6% |
Q2 2016 | $1,502,000 | +17.9% | 12,593 | +5.8% | 0.10% | +10.9% |
Q1 2016 | $1,274,000 | – | 11,899 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |